| 10/2/2024 | BK | Emergent BioSolutions closes on credit agreement via Wells Fargo
|
| 9/11/2024 | BKDDHY | S&P ups Emergent BioSolutions
|
| 9/6/2024 | BKDDHY | Moody's raises Emergent BioSolutions
|
| 9/3/2024 | BKPV | Emergent BioSolutions signs $250 million term loan agreement
|
| 8/16/2024 | BKCVDDEMIGPV | Market Commentary: Junk closes heavy volume week, pipeline expected to dwindle; Prime Healthcare improves
|
| 7/9/2024 | BKCVDDEMIGPV | Market Commentary: Cinemark, Watco price; Brightline improves; Emergent jumps
|
| 6/28/2024 | BKDDHY | S&P nicks Emergent BioSolutions
|
| 5/9/2024 | BKDDHY | Moody's stabilizes Emergent view
|
| 4/30/2024 | BK | Emergent BioSolutions amends credit agreement, reduces commitments
|
| 3/12/2024 | BKDDHY | S&P cuts Emergent BioSolutions
|
| 8/31/2023 | BKDDHY | S&P cuts Emergent BioSolutions
|
| 8/22/2023 | BKDDHY | Moody's prunes Emergent BioSolutions
|
| 5/18/2023 | BK | Emergent BioSolutions cuts facilities to $300 million, extends to 2025
|
| 3/3/2023 | BKDDHY | Moody's trims Emergent BioSolutions
|
| 2/16/2023 | BKCVDDEMIGPV | Market Commentary: Junk: CHS/Community Health active post-earnings; Service Properties, Emergent Bio jump
|
| 1/9/2023 | BKDDHY | Emergent BioSolutions expects restructuring to save over $60 million
|
| 11/14/2022 | BKDDHY | Moody's trims Emergent BioSolutions
|
| 11/10/2022 | BKHY | S&P slices Emergent BioSolutions
|
| 10/13/2022 | BKHY | Moody’s cuts Emergent BioSolutions
|
| 5/2/2022 | BKHY | Moody's cuts Emergent BioSolutions
|
| 11/10/2021 | BKHY | S&P shifts Emergent view to negative
|
| 4/30/2021 | BKCVHY | Moody's alters Emergent view to negative
|
| 4/20/2021 | BKCVDDEMIGPV | Market Commentary: High yield: Morgan Automotive prices; Jazz megadeal on tap; Charter flat; Emergent down again
|
| 8/5/2020 | BKCVDDEMIGPV | Market Commentary: Howard Hughes, Harvest Midstream, DSLD price; new deals trade up; index turns positive
|
| 8/4/2020 | BKCVDDEMIGPV | Market Commentary: Leviathan, Penske, Emergent, Element, Xerox price; Melco adds on; Service, Apache gain
|
| 8/4/2020 | BKCVHY | Moody’s gives Emergent BioSolutions Ba2, notes Ba3
|
| 8/4/2020 | BKCVHY | S&P rates Emergent BioSolutions BB, notes BB-
|
| 8/4/2020 | BK | Emergent BioSolutions seeks loan amendment with notes offering
|
| 10/15/2018 | BK | Emergent lifts revolver to $600 million, adds $450 million term loan
|
| 10/5/2018 | BK | Emergent BioSolutions draws on credit facility for PaxVax purchase
|
| 8/28/2018 | BK | Emergent Biosolutions gets $600 million debt commitment
|
| 10/2/2017 | BK | Emergent BioSolutions enters into $200 million five-year revolver
|
| 2/4/2014 | BK | Emergent repays $62 million of revolver, terminates unused term loan
|
| 12/12/2013 | BK | Emergent enters $100 million revolver, $125 million term loan
|
